Literature DB >> 7952624

Oxygen improves maximal exercise performance in interstitial lung disease.

A O Harris-Eze1, G Sridhar, R E Clemens, C G Gallagher, D D Marciniuk.   

Abstract

We examined whether arterial hypoxemia impairs incremental exercise performance in subjects with interstitial lung disease (ILD). Seven subjects underwent two incremental exercise tests on a bicycle ergometer in random order; one while breathing room air (RA), and the other while breathing 60% O2. Maximal exercise performance was impaired in all subjects: maximal oxygen uptake (peak VO2) was 56 +/- 4% predicted (+/- SEM); and all subjects demonstrated significant arterial oxygen desaturation during exercise breathing RA (mean 11 +/- 1%). Breathing 60% O2 during exercise resulted in a significant increase in peak VO2 (RA: 1.32 +/- 0.05 L/min; O2: 1.58 +/- 0.08 L/min; p < 0.05), exercise duration (RA: 390 +/- 21 s; O2: 458 +/- 24 s; p < 0.01) and maximal work load (RA: 112 +/- 6 watts; O2: 129 +/- 6 watts; p < 0.005). There was no significant difference in maximal minute ventilation (VI) achieved at the end of both tests. At matched ventilation (90% peak VI from the RA test), respiratory frequency (f) was significantly higher (RA: 33 +/- 2 breaths/min; O2: 35 +/- 2 breaths/min; p < 0.05), and tidal volume (VT) significantly lower (RA: 1.72 +/- 0.15 L; O2: 1.64 +/- 0.12; p < 0.05) when subjects exercised breathing oxygen. We conclude that arterial hypoxemia significantly impairs incremental exercise performance in subjects with ILD, but that mechanisms other than arterial oxygen desaturation are responsible for the rapid, shallow breathing pattern these subjects adopt during exercise.

Entities:  

Mesh:

Year:  1994        PMID: 7952624     DOI: 10.1164/ajrccm.150.6.7952624

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis.

Authors:  J L Hook; S M Arcasoy; D Zemmel; M N Bartels; S M Kawut; D J Lederer
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

Review 2.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

3.  Pulmonary Overlap Syndromes, with a focus on COPD and ILD.

Authors:  Katherine A Dudley; Atul Malhotra; Robert L Owens
Journal:  Sleep Med Clin       Date:  2014-09

4.  Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.

Authors:  Mary K Porteous; Belinda N Rivera-Lebron; Maryl Kreider; James Lee; Steven M Kawut
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 5.  Ambulatory and short-burst oxygen for interstitial lung disease.

Authors:  Charles Sharp; Huzaifa Adamali; Ann B Millar
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

6.  Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis.

Authors:  Camille Rolland-Debord; Stephanie Fry; Jonathan Giovannelli; Carole Langlois; Nicolas Bricout; Bernard Aguilaniu; Agnes Bellocq; Olivier Le Rouzic; Stephane Dominique; Alain Delobbe; Geraldine François; Abdellatif Tazi; Benoit Wallaert; Cecile Chenivesse
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

7.  Spiroergometric measurements under increased inspiratory oxygen concentration (FIO2)-Putting the Haldane transformation to the test.

Authors:  Stephan Lang; Robert Herold; Alexander Kraft; Volker Harth; Alexandra M Preisser
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 8.  IPF Respiratory Symptoms Management - Current Evidence.

Authors:  Piotr Janowiak; Amelia Szymanowska-Narloch; Alicja Siemińska
Journal:  Front Med (Lausanne)       Date:  2022-07-28

Review 9.  Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.

Authors:  Renata G Mendes; Viviane Castello-Simões; Renata Trimer; Adriana S Garcia-Araújo; Andrea Lucia Gonçalves Da Silva; Snehil Dixit; Valéria Amorim Pires Di Lorenzo; Bruno Archiza; Audrey Borghi-Silva
Journal:  Front Rehabil Sci       Date:  2021-11-16

10.  A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease.

Authors:  Anne Edvardsen; Inga Jarosch; Anita Grongstad; Laura Wiegand; Rainer Gloeckl; Klaus Kenn; Martijn A Spruit
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.